{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:49:48Z","timestamp":1773539388745,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972824"],"award-info":[{"award-number":["81972824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","award":["2023B1212060022"],"award-info":[{"award-number":["2023B1212060022"]}],"id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515011513"],"award-info":[{"award-number":["2020A1515011513"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118548","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T23:25:56Z","timestamp":1767482756000},"page":"118548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Computer-Aided optimization of quinazoline-based Aurora kinase inhibitors for enhanced metabolic stability"],"prefix":"10.1016","volume":"305","author":[{"given":"Song","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0089-0907","authenticated-orcid":false,"given":"Gui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118548_bib1","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/jm8012129","article-title":"Discovery and development of Aurora kinase inhibitors as anticancer agents","volume":"52","author":"Pollard","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The Aurora kinases in cell cycle and leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118548_bib3","doi-asserted-by":"crossref","first-page":"134935","DOI":"10.1016\/j.molstruc.2023.134935","article-title":"A comprehension on synthetic strategies of Aurora kinase A and B inhibitors","volume":"1278","author":"Jaswal","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118548_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5507\/bp.2008.004","article-title":"Aurora kinases: structure, functions and their association with cancer","volume":"152","author":"Kollareddy","year":"2008","journal-title":"Biomed. Pap."},{"key":"10.1016\/j.ejmech.2025.118548_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.biocel.2005.02.021","volume":"37","author":"Bolanos-Garcia","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118548_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113495","article-title":"Aurora kinase inhibitors as potential anticancer agents: recent advances","volume":"221","author":"Pradhan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26351","article-title":"A phase I\/II trial of AT9283, a selective inhibitor of Aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia","volume":"64","author":"Vormoor","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejmech.2025.118548_bib8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/annonc\/mdw281","article-title":"Phase II study of MLN8237 (alisertib) in advanced\/metastatic sarcoma","volume":"27","author":"Dickson","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2025.118548_bib9","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1200\/jco.2011.29.15_suppl.5021","article-title":"A phase II study of ENMD-2076 in platinum-resistant ovarian cancer","volume":"29","author":"Matulonis","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118548_bib10","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.4161\/cc.6.22.4940","article-title":"VX-680 inhibits Aurora A and Aurora B kinase activity in human cells","volume":"6","author":"Tyler","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2025.118548_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1517\/13543776.2014.931374","article-title":"Aurora kinase inhibitor patents and agents in clinical testing: an update (2011-2013)","volume":"24","author":"Cheung","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.118548_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/1535-7163.MCT-10-0574","article-title":"ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action","volume":"10","author":"C Fletcher","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.118548_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1021\/acs.jmedchem.4c01933","article-title":"Structure-based rational design and evaluation of BET-Aurora kinase dual-inhibitors for treatment of cancers","volume":"68","author":"Lyu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117735","article-title":"Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl) acetamide as the first orally active selective Aurora kinase B inhibitor","volume":"294","author":"Tran","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116917","article-title":"Discovery of new pyrazole-4-carboxamide analogues as potential anticancer agents targeting dual Aurora kinase A and B","volume":"280","author":"Yevale","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117729","article-title":"First-in-class dual inhibitors of MASTL and Aurora A kinase: discovery of selective cyclohexa[b]thiophenes with potent anticancer activity","volume":"293","author":"Abdel-Rahman","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib17","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1021\/acs.jmedchem.4c01165","article-title":"Selective Aurora A-TPX2 interaction inhibitors have in vivo efficacy as targeted antimitotic agents","volume":"67","author":"Stockwell","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.03.027","article-title":"Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent Aurora A kinase inhibitors","volume":"78","author":"Luo","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejmech.2017.12.082","article-title":"Synthesis and biological evaluation of Aurora kinases inhibitors based on N-trisubstituted pyrimidine scaffold","volume":"145","author":"Long","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ejmech.2018.08.053","article-title":"Structure-based drug design: synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors","volume":"157","author":"Long","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115457","article-title":"Discovery of a first-in-class Aurora A covalent inhibitor for the treatment of triple negative breast cancer","volume":"256","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib22","doi-asserted-by":"crossref","first-page":"18197","DOI":"10.1021\/acs.jmedchem.5c00107","article-title":"Optimization of novel quinazolines as potent Aurora kinase inhibitors for triple negative breast cancer treatment","volume":"68","author":"Long","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118548_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22159","article-title":"Piquing artificial intelligence towards drug discovery: tools, techniques, and applications","volume":"85","author":"Agu","year":"2024","journal-title":"Drug Develop. Res."},{"key":"10.1016\/j.ejmech.2025.118548_bib24","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/bioinformatics\/btz037","article-title":"SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server","volume":"35","author":"Olsen","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118548_bib25","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/bioinformatics\/btv087","article-title":"SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds","volume":"31","author":"Rudik","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118548_bib26","doi-asserted-by":"crossref","first-page":"W115","DOI":"10.1093\/nar\/gkac313","article-title":"BioTransformer 3.0-a web server for accurately predicting metabolic transformation products","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118548_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:06:47Z","timestamp":1773536807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425013133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"alternative-id":["S0223523425013133"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118548","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computer-Aided optimization of quinazoline-based Aurora kinase inhibitors for enhanced metabolic stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118548"}}